Posted on Thursday, July 11th, 2024
From investigating the mechanisms of cancer cells and chronic pain to shaping new policies for microbiome health, nine University of Guelph researchers have received over $7.1 million in federal grants from the Canadian Institutes of Health Research (CIHR).
Insights from these projects could lead to new treatments for life-threatening diseases such as breast cancer, chronic kidney disease, leukemia, and more.
College of Biological Science
- Dr. Shaun Sanders, Department of Microbiology and Cellular Biology (MCB), will receive $808,349 to better understand ion channels in neurons.
- Dr. Graham Holloway, Department of Human Health and Nutritional Sciences, has received $791,776 to study dietary nitrate and how it might mitigate the consequences of physical inactivity.
- Dr. Nina Jones, MCB, has been granted $879,750 to study specialized kidney cells called podocytes, whose functions are disrupted during early kidney disease.
- Dr. Siavash Vahidi, MCB, has received $1,143,375 to investigate acute myeloid leukemia (AML) cells.
College of Social and Applied Human Sciences
- Dr. Kieran O’Doherty, Department of Psychology, has received $707,624 to investigate society’s relationship to the human microbiome.
Ontario Veterinary College
- Dr. Giannina Descalzi, Department of Biomedical Sciences, has received $1,086,300 to understand the mechanisms and networks in the brain that cause chronic pain, which is experienced by one in four Canadians over the age of 15.
- Dr. Samuel Tekeste Workenhe, Department of Pathobiology, has received $925,650 to investigate the process of cell death and the cellular alarm signals that alert the immune system to destroy cancer cells.
- Dr. Roger Moorehead, Department of Biomedical Sciences, has received $100,000 to study a protein shown to reduce the growth and spread of breast cancer cells to the lungs.
- Dr. Sarah Wootton, Department of Pathobiology, received $761,176 to enhance and expand her group’s patented alternative vaccine system, which has been shown to be effective against a range of infectious diseases, including Ebola and Pseudomonas aeruginosa.
Read the full news release on the U of G News site: U of G Researchers Receive Federal Funding to Study Cancer, Chronic Pain and More.